1. Tanshinone IIA promotes apoptosis by downregulating BCL2 and upregulating TP53 in triple-negative breast cancer
   Jinfeng Liu et al, 2023, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
2. Crosstalk Between ROS and Autophagy in Tumorigenesis: Understanding the Multifaceted Paradox
   Adria Hasan et al, 2022, Frontiers in Oncology CrossRef
3. An overview of the anti-cancer actions of Tanshinones, derived from Salvia miltiorrhiza (Danshen)
   Irum Naz et al, 2020, Exploration of Targeted Anti-tumor Therapy CrossRef
4. Yangxue Jiedu Fang Ameliorates Psoriasis by Regulating Vascular Regression via Survivin/PI3K/Akt Pathway
   Hongpeng Lv et al, 2021, Journal of Immunology Research CrossRef
5. Metabolic adaption of cancer cells toward autophagy: Is there a role for ER-phagy?
   Debora Gentile et al, 2022, Frontiers in Molecular Biosciences CrossRef
6. Recent Research Progress (2015–2021) and Perspectives on the Pharmacological Effects and Mechanisms of Tanshinone IIA
   Chenhui Zhong et al, 2021, Frontiers in Pharmacology CrossRef
7. Mechanisms and Molecular Targets of Compound Danshen Dropping Pill for Heart Disease Caused by High Altitude Based on Network Pharmacology and Molecular Docking
   Jiayi Yan et al, 2021, ACS Omega CrossRef
8. Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug
   Hu Li et al, 2023, Frontiers in Oncology CrossRef
9. Molecular Mechanism of Tanshinone against Prostate Cancer
   Wei Li et al, 2022, Molecules CrossRef
10. The Intricate Crosstalk Between Insulin and Pancreatic Ductal Adenocarcinoma: A Review From Clinical to Molecular
    Junyuan Deng et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
11. Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway
    Huayuan Liu et al, 2021, Scientific Reports CrossRef
12. The mechanisms of tanshinone in the treatment of tumors
    Pengyu Zhang et al, 2023, Frontiers in Pharmacology CrossRef